-
1
-
-
0014545138
-
Vascular pathology of homocysteinemia: Implication for the pathogenesis of atherosclerosis
-
Mc Cully KS. Vascular pathology of homocysteinemia: implication for the pathogenesis of atherosclerosis. American J Pathology 1969, 56: 111-128.
-
(1969)
American J Pathology
, vol.56
, pp. 111-128
-
-
Mc Cully, K.S.1
-
2
-
-
0028788020
-
Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteiene study
-
Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteiene study. Journal of American Medical Association 1995; 274: 1526-1533.
-
(1995)
Journal of American Medical Association
, vol.274
, pp. 1526-1533
-
-
Nygard, O.1
Vollset, S.E.2
Refsum, H.3
-
3
-
-
0029066299
-
A quantitative assessment of plasma homocysteine as a risk factor for cardiovascular disease. Probable benefits of increasing folic and intakes
-
Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for cardiovascular disease. Probable benefits of increasing folic and intakes. Journal of American Medical Association 1995; 274: 1049-1057.
-
(1995)
Journal of American Medical Association
, vol.274
, pp. 1049-1057
-
-
Boushey, C.J.1
Beresford, S.A.2
Omenn, G.S.3
Motulsky, A.G.4
-
4
-
-
0021752123
-
Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease
-
Brattstrom L, Hardebo JE, Hultberg BJ. Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984; 15: 1012-1016.
-
(1984)
Stroke
, vol.15
, pp. 1012-1016
-
-
Brattstrom, L.1
Hardebo, J.E.2
Hultberg, B.J.3
-
5
-
-
0028966321
-
Association between plasma homocysteine concentrations and extracranial carotid artery stenosis
-
Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid artery stenosis. New England Journal of Medicine 1995; 332: 286-291.
-
(1995)
New England Journal of Medicine
, vol.332
, pp. 286-291
-
-
Selhub, J.1
Jacques, P.F.2
Bostom, A.G.3
-
6
-
-
0025756673
-
Hyperhomocysteinemia as an indipendent risk factor for vascular disease
-
Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia as an indipendent risk factor for vascular disease. New England Journal of Medicine 1991, 1149-1155.
-
(1991)
New England Journal of Medicine
, pp. 1149-1155
-
-
Clarke, R.1
Daly, L.2
Robinson, K.3
-
7
-
-
0026684554
-
-
Stampfer M, et al. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of plasma homocysteine and risk of myocardial infarction in U.S. phisicians. Journal of American Medical Association 1992, 268: 877-881.
-
Stampfer M, et al. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of plasma homocysteine and risk of myocardial infarction in U.S. phisicians. Journal of American Medical Association 1992, 268: 877-881.
-
-
-
-
9
-
-
0025886577
-
Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease
-
Sep-Oct;
-
Genest JJ Jr, McNamara JR, Upson B, Salem DN, Ordovas JM, Schaefer EJ, Malinow. Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease. Arterioscler Thromb 1991 Sep-Oct; 11 (5): 1129-36.
-
(1991)
Arterioscler Thromb
, vol.11
, Issue.5
, pp. 1129-1136
-
-
Genest Jr, J.J.1
McNamara, J.R.2
Upson, B.3
Salem, D.N.4
Ordovas, J.M.5
Schaefer, E.J.6
Malinow7
-
10
-
-
1842331509
-
Plasma homocysteine as a risk factor for vascular disease
-
The European Concerted Action Project
-
The European Concerted Action Project. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997; 277: 1775-1781.
-
(1997)
JAMA
, vol.277
, pp. 1775-1781
-
-
-
11
-
-
0025879850
-
The prevalence of homocysteinemia and hypercolesterolemia in angiographically defined coronary artery disease
-
Ubbink JB. The prevalence of homocysteinemia and hypercolesterolemia in angiographically defined coronary artery disease. Klinishe Wochenschrift 1991; 69: 527-534.
-
(1991)
Klinishe Wochenschrift
, vol.69
, pp. 527-534
-
-
Ubbink, J.B.1
-
12
-
-
1842370239
-
Plasma homocysteine levels and mortality in patients with coronary artery disease
-
Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine 1997; 337: 230-236
-
(1997)
New England Journal of Medicine
, vol.337
, pp. 230-236
-
-
Nygard, O.1
Nordrehaug, J.E.2
Refsum, H.3
Ueland, P.M.4
Farstad, M.5
Vollset, S.E.6
-
13
-
-
0344306693
-
Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium
-
Stanger O, Weger M. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium. Clin Chem Lab Med 2003; 41: 1444-54.
-
(2003)
Clin Chem Lab Med
, vol.41
, pp. 1444-1454
-
-
Stanger, O.1
Weger, M.2
-
14
-
-
24444472604
-
Homocysteine reduction-oxidation (Redox)-Receptor and regulation of extracellular matrix component in human vascular smooth muscle cells
-
Tyagi SC. Homocysteine reduction-oxidation (Redox)-Receptor and regulation of extracellular matrix component in human vascular smooth muscle cells. FASEB J 1997; 11: 3, A288.
-
(1997)
FASEB J
, vol.11
, Issue.3
-
-
Tyagi, S.C.1
-
15
-
-
0031935068
-
Homocysteine Redox-Receptor and regulation of extracellular matrix component in vascular cells
-
Tyagi SC. Homocysteine Redox-Receptor and regulation of extracellular matrix component in vascular cells. Am J Physiol 1998; 274: C396-C405.
-
(1998)
Am J Physiol
, vol.274
-
-
Tyagi, S.C.1
-
16
-
-
0032928601
-
Homocysteine and heart disease: Pathophysiology of extracellular matrix
-
Tyagi SC. Homocysteine and heart disease: pathophysiology of extracellular matrix. Clin and Exper Hypertension 1999; 21: 181-198.
-
(1999)
Clin and Exper Hypertension
, vol.21
, pp. 181-198
-
-
Tyagi, S.C.1
-
18
-
-
0033854330
-
Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients
-
Cooke GE, Eaton GM, Whitby G, Kennedy RA, Binkley PF, Moeschberger ML, Leier CV. Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients. J Am Coll Cardiol 2000; 36: 509-16.
-
(2000)
J Am Coll Cardiol
, vol.36
, pp. 509-516
-
-
Cooke, G.E.1
Eaton, G.M.2
Whitby, G.3
Kennedy, R.A.4
Binkley, P.F.5
Moeschberger, M.L.6
Leier, C.V.7
-
19
-
-
0035652251
-
Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects
-
Ventura P, Panini R, Verlato C, Scarpetta G, Salvioli G. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects. Metabolism 2001; 50: 1466-71.
-
(2001)
Metabolism
, vol.50
, pp. 1466-1471
-
-
Ventura, P.1
Panini, R.2
Verlato, C.3
Scarpetta, G.4
Salvioli, G.5
-
20
-
-
11144356292
-
Relations of plasma homocysteine to left ventricular structure and function: The Framingham Heart Study
-
Sundstrom J, Sullivan L, Selhub J, et al. Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study. Eur Heart J 2004; 25: 523-30.
-
(2004)
Eur Heart J
, vol.25
, pp. 523-530
-
-
Sundstrom, J.1
Sullivan, L.2
Selhub, J.3
-
21
-
-
0037433466
-
Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction
-
Vasan RS, Beiser A, D'Agostino RB, et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA 2003; 289: 1251-1257.
-
(2003)
JAMA
, vol.289
, pp. 1251-1257
-
-
Vasan, R.S.1
Beiser, A.2
D'Agostino, R.B.3
-
22
-
-
0036889964
-
Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats
-
Joseph J, Washington A, Joseph L, et al. Hyperhomocysteinemia leads to adverse cardiac remodeling in hypertensive rats. Am J Physiol Heart Circ Physiol 2002; 283: H2567-74.
-
(2002)
Am J Physiol Heart Circ Physiol
, vol.283
-
-
Joseph, J.1
Washington, A.2
Joseph, L.3
-
23
-
-
2542436169
-
Effect of experimental hyperhomocysteinemia on cardiac structure and function in the rat
-
Walker E, Black J, Parris C, et al. Effect of experimental hyperhomocysteinemia on cardiac structure and function in the rat. Ann Clin Lab Sci 2004; 34: 175-80.
-
(2004)
Ann Clin Lab Sci
, vol.34
, pp. 175-180
-
-
Walker, E.1
Black, J.2
Parris, C.3
-
24
-
-
0037623866
-
Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats
-
Joseph J, Joseph L, Shekhawat NS, et al. Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. Am J Physiol Heart Circ Physiol 2003; 285: H679-86.
-
(2003)
Am J Physiol Heart Circ Physiol
, vol.285
-
-
Joseph, J.1
Joseph, L.2
Shekhawat, N.S.3
-
26
-
-
0034127659
-
Myocardial matrix degradation and metalloproteinase activation in the failing heart: A potential therapeutic target
-
Spinale FG, Coker ML, Bond BR, Zellner JL. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. Cardiovasc Res 2000; 46: 225-38.
-
(2000)
Cardiovasc Res
, vol.46
, pp. 225-238
-
-
Spinale, F.G.1
Coker, M.L.2
Bond, B.R.3
Zellner, J.L.4
-
27
-
-
2442457887
-
Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: Its inhibition as a primary effect of Angiotensinconverting enzyme inhibitor
-
Sakata Y, Yamamoto K, Mano T, et al. Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensinconverting enzyme inhibitor. Circulation 2004; 109: 2143-9.
-
(2004)
Circulation
, vol.109
, pp. 2143-2149
-
-
Sakata, Y.1
Yamamoto, K.2
Mano, T.3
-
28
-
-
0034785723
-
Matrix metalloproteinase inhibition and the prevention of heart failure
-
Lee RT. Matrix metalloproteinase inhibition and the prevention of heart failure. Trends Cardiovasc Med 2001; 11: 202-5.
-
(2001)
Trends Cardiovasc Med
, vol.11
, pp. 202-205
-
-
Lee, R.T.1
-
29
-
-
0034885377
-
Matrix metalloproteinases in the progression of heart failure: Potential therapeutic implications
-
Li YY, Feldman AM. Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications. Drugs 2001; 61: 1239-52.
-
(2001)
Drugs
, vol.61
, pp. 1239-1252
-
-
Li, Y.Y.1
Feldman, A.M.2
-
30
-
-
5644304359
-
Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression
-
Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression. J Am Coll Cardiol 2004; 44: 1609-18.
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 1609-1618
-
-
Polyakova, V.1
Hein, S.2
Kostin, S.3
Ziegelhoeffer, T.4
Schaper, J.5
-
31
-
-
0037371849
-
Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation
-
Nishikawa N, Yamamoto K, Sakata Y, et al. Differential activation of matrix metalloproteinases in heart failure with and without ventricular dilatation. Cardiovasc Res 2003; 57: 766-74.
-
(2003)
Cardiovasc Res
, vol.57
, pp. 766-774
-
-
Nishikawa, N.1
Yamamoto, K.2
Sakata, Y.3
-
32
-
-
0842283185
-
Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure
-
Yamazaki T, Lee JD, Shimizu H, Uzui H, Ueda T. Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure. Eur J Heart Fail 2004; 6: 41-5
-
(2004)
Eur J Heart Fail
, vol.6
, pp. 41-45
-
-
Yamazaki, T.1
Lee, J.D.2
Shimizu, H.3
Uzui, H.4
Ueda, T.5
-
33
-
-
0036182632
-
Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats
-
Miller A, Mujumdar V, Palmer L, et al. Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hypertens 2002; 5 (2 Pt 1): 157-63.
-
(2002)
Am J Hypertens
, vol.5
, Issue.2 PART 1
, pp. 157-163
-
-
Miller, A.1
Mujumdar, V.2
Palmer, L.3
-
34
-
-
0025095390
-
Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment
-
Brattstrom L, Israelsson B, Norrving B, et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 1990; 81: 51-60. 49.
-
(1990)
Atherosclerosis
, vol.81
, Issue.51-60
, pp. 49
-
-
Brattstrom, L.1
Israelsson, B.2
Norrving, B.3
-
35
-
-
0029066299
-
A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
-
Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049 -57.
-
(1995)
JAMA
, vol.274
, pp. 1049-1057
-
-
Boushey, C.J.1
Beresford, S.A.A.2
Omenn, G.S.3
Motulsky, A.G.4
-
37
-
-
0033533527
-
Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
-
Eikelboom JW, Lonn E, Genest J, et al. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999; 131: 363-375.
-
(1999)
Ann Intern Med
, vol.131
, pp. 363-375
-
-
Eikelboom, J.W.1
Lonn, E.2
Genest, J.3
|